What Should a Clinical Research Site Look for in a Recruitment Marketing Partner?

When enrollment slows, a Research Site may decide it needs outside recruitment support. That decision usually leads to another question: which recruitment marketing partner should we choose?

The answer should involve much more than comparing Cost Per Lead. A clinical trial recruitment partner may influence how the Study is presented to prospective participants, which geographic markets receive advertising spend, how participant-facing materials are developed, what happens after someone responds, how referrals reach the Site, how recruitment performance is measured, and ultimately how efficiently the Site converts marketing investment into meaningful participant opportunities.

The right partner should therefore understand more than advertising platforms. It should understand how clinical research recruitment actually works.

Start by Asking What the Partner Actually Does

“Patient recruitment” can describe very different services. One company may primarily provide media buying. Another may provide lead generation. Another may provide pre-screened referrals. Another may combine strategy, creative, advertising, preliminary pre-screening, communication workflows, reporting, and referral management.

None of those models is automatically wrong. The problem begins when the Research Site believes it is purchasing one service but receives another.

Before signing an agreement, ask: what exactly happens between our Study information and the referral that reaches our Site? A strong provider should be able to explain that process clearly.

1. Look for Clinical Research Experience, Not Just Healthcare Marketing Experience

Healthcare marketing and clinical research marketing overlap, but they are not identical. A traditional healthcare agency may be very good at physician marketing, hospital campaigns, elective procedures, appointment generation, or patient acquisition.

Clinical research adds another layer. The marketer must understand that an advertising response is not an enrolled participant, Study eligibility cannot be determined through advertising alone, participant-facing recruitment materials can require IRB review, investigational products cannot be marketed as proven treatments, and the recruitment funnel continues long after the initial lead.

FDA considers direct advertising used to recruit research subjects part of the informed-consent and subject-selection process, and expects applicable recruitment materials and methods to receive appropriate IRB review. That regulatory context should influence how the marketing partner writes, designs, revises and manages recruitment creative. A provider unfamiliar with these realities may create unnecessary delays or inappropriate expectations.

2. The Partner Should Understand the Study Before Launching Ads

Be cautious if the first questions are “What is your budget?” and “Do you want Facebook or Google?” Those questions matter. They should not be the first questions.

A recruitment strategy should begin with therapeutic area, protocol population, age range, geography, Site location, major recruitment barriers, visit burden, language needs, Site capacity, and the participant journey. Only after understanding those factors should channel selection become central.

A strong recruitment partner should ask enough questions to understand the Study before recommending a campaign. Otherwise, the strategy risks becoming generic advertising with a clinical-trial headline.

3. Ask How They Handle IRB-Reviewed Creative

Clinical research recruitment requires a different creative workflow from ordinary advertising. FDA guidance states that IRBs should review recruitment advertising to ensure, among other things, that it is not coercive and does not promise favorable outcomes beyond what is supported by the protocol and consent materials. FDA also cautions against presenting an investigational product as safe or effective for the purpose being studied.

A recruitment marketing partner should therefore understand IRB submission workflows, version control, approved versus unapproved creative, video scripts, static advertisements, landing-page or form content, bilingual materials, and what happens when an IRB requests revisions.

Ask: how do you manage creative changes after IRB approval? If the answer is essentially “We just change the ad when performance drops,” that should trigger additional questions. Digital marketing requires optimization. Clinical research marketing requires controlled optimization.

4. Look for a Partner That Plans Creative Variation in Advance

A Study may recruit for months. One advertisement may not remain effective for the entire recruitment period. A strong partner should think ahead about multiple creative concepts, video versus static content, different aspect ratios, alternate approved headlines, English and Spanish versions, caregiver-oriented versus participant-oriented messaging, and creative refreshes.

FDA’s recruitment guidance specifically notes the practical value of reviewing advertising wording before final video production, which can reduce unnecessary re-recording when changes are required. This is not merely a regulatory issue. It is also good campaign planning. The more appropriate creative flexibility exists before launch, the easier it becomes to respond to performance changes later.

5. Do Not Choose a Partner Based Only on Cost Per Lead

A vendor promises $25 leads. Another estimates $40 leads. The first one appears cheaper. But what happens downstream?

Consider two hypothetical vendors. Vendor A generates 300 leads at $25 CPL, producing 30 meaningful referrals. Vendor B generates 180 leads at $40 CPL, producing 60 meaningful referrals. Vendor A appears better when evaluated by lead cost. Vendor B may be substantially better when evaluated by referral production. The numbers are illustrative. The lesson is not.

Research Sites should ask potential partners which metrics they report after initial acquisition. Ideally, reporting should progressively connect:

Spend → Inquiry → Contact → Pre-Screen → Referral → Site Screening → Enrollment

Not every marketing provider will have access to every downstream Site metric. But a strong partner should at least want that data. If the provider is satisfied once the lead is delivered, while the Site is measured on enrollment, the two organizations may not be optimizing toward the same outcome.

6. Ask How They Define a “Qualified Lead”

This term deserves special attention. Different companies use “qualified lead” to mean very different things. It could mean someone completed a form, someone answered one qualifying question, someone completed preliminary pre-screening, someone spoke with a recruiter, someone appeared to meet basic Study criteria, or someone was accepted for Site screening.

Those are not equivalent. Research Sites should ask for a precise definition — for example, what must happen before you call someone a qualified referral? The answer should distinguish preliminary recruitment criteria from formal Study eligibility. A marketing partner should not imply that it can determine final clinical eligibility when that determination belongs within the appropriate protocol-based Site process. Clear terminology protects expectations on both sides.

7. Evaluate the Recruitment Funnel, Not Just the Advertising

A strong marketing partner should be interested in what happens after the click, including registration experience, preliminary pre-screening, confirmation messages, participant communication, referral routing, status tracking, and Site handoff.

This does not mean the marketing company has to perform every function. But it should understand them. If the partner generates 500 leads without asking how your Site handles those leads, it cannot fully understand campaign performance. That matters because a bottleneck after acquisition can make a good campaign look ineffective. As discussed in How Research Sites Can Improve Participant Recruitment Without Increasing Ad Spend and The Hidden Cost of Slow Follow-Up in Clinical Research Recruitment, slow follow-up and funnel friction can destroy value without any change in advertising performance.

8. Ask About Response-Time Strategy

Digital advertising generates inquiries outside business hours. A recruitment partner should anticipate that reality. Ask: what happens when someone registers at 10 p.m.? Does the participant receive confirmation? When does human follow-up begin? Who owns the lead before it reaches the Site? What happens on weekends? How are missed contacts handled?

A useful recruitment system creates continuity between advertising, registration, communication, referral and Site. A weak system leaves gaps. Those gaps are where recruitment opportunities disappear.

9. Look for Transparent Reporting

Research Sites should understand where their money goes. Reporting should make it possible to see media spend, campaign performance, leads or inquiries, geography, creative performance, funnel progression, referrals, and relevant downstream outcomes when available.

A partner should also be willing to discuss poor performance. No recruitment campaign performs perfectly all the time. The question is whether the provider can identify what is underperforming and what should change.

Be cautious of reporting designed primarily to look impressive. Metrics such as impressions, reach, clicks and video views may demonstrate activity. They do not prove recruitment effectiveness. A useful dashboard should support decisions.

10. Ask Who Owns the Advertising Accounts and Data

This is an important operational question. Research Sites should understand who owns the advertising account, who controls the pixel or tracking infrastructure, who owns creative assets, whether campaign data can be exported, what happens to historical performance data if the relationship ends, and whether participant information is stored by third parties.

The answer may vary depending on the service model. What matters is transparency. A Site should not discover after ending a vendor relationship that it no longer has access to months of campaign history or critical recruitment data.

11. Evaluate Privacy and Data Handling

Recruitment can involve personal and sensitive information. FDA’s recruitment guidance specifically raises questions about how information gathered by marketing companies is handled, including whether names are retained, shared or sold and how records are protected or destroyed.

That makes data practices a legitimate vendor-selection question. Research Sites should understand what information the partner collects, why it is collected, where it is stored, who can access it, how long it is retained, whether third-party systems are involved, and what happens when a person does not progress.

The exact legal and compliance obligations depend on the workflow and circumstances. The marketing partner should not pretend every recruitment workflow has identical privacy requirements. But it should demonstrate that data handling has been deliberately considered.

12. Bilingual Capability Should Extend Beyond Translation

If the Study recruits English- and Spanish-speaking populations, ask what “bilingual recruitment” actually means. Does the provider simply translate the advertisement? Or can it support Spanish creative, localization, Spanish forms, participant-facing messaging, bilingual follow-up, Spanish video, and consistent participant communication?

A Spanish advertisement connected to an English-only recruitment workflow is not a complete bilingual strategy. The marketing partner should understand the entire participant journey. This issue is explored in depth in English vs Spanish Clinical Trial Campaigns: Why Translation Alone Is Not Enough

13. Multi-Site Experience Matters for CROs and SMOs

Recruiting for one Site is different from recruiting for twelve. Multi-Site campaigns may require geographic territories, referral routing, Site-level reporting, different budget allocations, Site capacity monitoring, overlapping markets, centralized creative, and local performance analysis.

A provider serving CROs or SMOs should be able to explain how it manages these issues. Ask: how do you decide where each referral goes? And how do you compare performance between Sites? If every Site simply receives the same budget regardless of population, capacity or performance, the strategy may not be truly centralized.

14. Look for a Partner Willing to Challenge Assumptions

A strong partner should not automatically agree with every request. Suppose the Site says, “We need twice as many leads.” The partner should be willing to ask why. Perhaps the Site already receives enough inquiries but loses most before contact. Perhaps geographic targeting is too broad. Perhaps the registration form creates friction. Perhaps a Spanish campaign has no Spanish follow-up. Perhaps referral volume is good but Site capacity is limited.

Increasing budget in those situations could make the problem worse. A strategic partner should help diagnose the recruitment problem rather than simply sell more media.

15. Ask How They Handle Underperformance

Before signing a contract, ask what happens when the campaign is not working. A strong answer might involve examining creative, geography, audience, response time, form completion, preliminary qualification, referral rates, Site feedback, and downstream outcomes.

A weak answer might simply be, “We increase the budget.” Optimization should follow the bottleneck. Not every recruitment problem is an advertising problem.

16. Understand the Commercial Model

Recruitment marketing can be priced in many ways: monthly management fee, percentage of media spend, flat campaign fee, cost per lead, cost per referral, project-based pricing, or combinations of these.

No model is automatically superior. The Site should understand what behavior the pricing model incentivizes. A pure Cost Per Lead arrangement creates a strong incentive to produce lead volume. A Cost Per Referral model may focus attention deeper in the funnel. A management-fee model may provide more flexibility but requires strong reporting.

The important issue is alignment. The partner’s financial incentive should not conflict with the Study’s recruitment objective.

17. Look for Strategic Capability Beyond a Single Study

The strongest relationship may eventually provide value beyond one recruitment campaign. Research Sites also need to think about digital presence, Site positioning, Sponsor and CRO visibility, recruitment infrastructure, CRM systems, multilingual capabilities, participant communication, analytics, and business development.

A specialized clinical research marketing partner may therefore contribute to both Study recruitment and long-term Site growth. This is an important distinction. A lead vendor solves one transaction. A strategic marketing partner can help build infrastructure that improves multiple Studies over time.

Questions to Ask Before Choosing a Recruitment Marketing Partner

A Research Site evaluating vendors should consider asking:

What clinical research recruitment experience do you have?
How do you learn the Study before developing the campaign?
How do you work with IRB-reviewed recruitment materials?
How do you define a lead, pre-screened opportunity and referral?
Which metrics do you report beyond CPL?
How do you handle participant follow-up?
How do you manage after-hours registrations?
How do you support bilingual recruitment?
How do you route referrals for multi-Site Studies?
How is participant information handled?
Who owns the advertising accounts, data and creative assets?
What happens when campaign performance declines?
How do you use Site feedback to optimize advertising?
How is your pricing structured?
What specifically will our Site receive from you each month?

A good partner should be comfortable answering these questions.

The Best Recruitment Partner Should Help the Site Learn

There is another characteristic that is easy to overlook. A strong recruitment marketing partner should make the Research Site more informed, not more dependent.

Over time, the Site should better understand which geographic areas perform, which participant messages resonate, which Studies are more difficult to recruit, which channels produce stronger referrals, where its funnel loses people, and which operational improvements increase conversion. That knowledge becomes an organizational asset. Recruitment marketing should not operate as a mysterious black box.

Do Not Buy Leads. Buy a Better Recruitment System.

Research Sites naturally need participants. That can make lead volume feel like the obvious product to purchase. But the most valuable recruitment partner may be the one that asks deeper questions: Who are we trying to reach? What will they experience after responding? How will recruitment materials be managed? How quickly will the Site respond? How will referrals be defined? How will outcomes be measured? Where is the actual bottleneck?

The objective is not merely to find a company capable of running advertisements. It is to find a partner capable of helping connect:

Study Strategy → Recruitment Creative → Digital Acquisition → Participant Engagement → Referral → Site Screening → Recruitment Performance

When those pieces work together, marketing becomes part of the recruitment operation rather than an isolated source of leads. That is the standard Research Sites should use when evaluating a clinical trial recruitment marketing partner.

Frequently Asked Questions

What does a clinical trial recruitment marketing company do?

Services vary. A provider may offer advertising, recruitment creative, media buying, preliminary pre-screening, participant communication, referral generation, reporting or broader recruitment strategy. Research Sites should confirm exactly which services are included.

Should a Research Site choose the vendor with the lowest Cost Per Lead?

Not necessarily. CPL measures acquisition cost but does not show how many inquiries become meaningful referrals, Site screenings or enrollments. Downstream recruitment performance should be considered whenever possible.

Should a recruitment marketing partner understand IRB requirements?

Yes. The provider does not replace the IRB or provide regulatory authority, but it should understand how IRB review affects participant-facing recruitment materials and campaign workflows.

What should a Site ask about participant data?

Sites should understand what information is collected, why it is collected, where it is stored, who can access it, how it is retained, and how it moves between the recruitment provider and the Research Site.

Is a specialized clinical research marketing agency better than a general healthcare agency?

Not automatically. The important question is whether the provider understands clinical research recruitment, participant workflows, IRB-aware creative, Site operations, recruitment metrics and the specific needs of the Study.